Login Register Cart 0
Generic placeholder image

Current Medical Imaging

Editor-in-Chief

ISSN (Print): 1573-4056
ISSN (Online): 1875-6603

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Imaging Strategies for Rectal Cancer Initial Staging: Does Pelvic Computed Tomography Provide Significantly Additional Findings when High-resolution Magnetic Resonance Imaging has Been Performed?

Author(s): Li-Yan Liu and Li-Heng Liu*

Volume 16, Issue 8, 2020

Page: [1029 - 1033] Pages: 5

DOI: 10.2174/1573405615666191019092606

Abstract

Background: Initial staging of rectal cancer is done by high-resolution magnetic resonance imaging (MRI), however, pelvic computed tomography (CT) is also frequently used. The aim of this study was to evaluate the added clinical benefit of pelvic CT or whether it can alter the initial staging or not.

Methods: The study was composed of 187 patients with rectal cancer. Firstly, imaging except pelvic CT was evaluated. Secondly, the pelvic CT was evaluated and the staging was adjusted according to the new findings. Subsequently, the two staging results were compared to investigate the added clinical benefit of pelvic CT.

Results: Compared with the imaging data except pelvic CT, new findings revealed by the pelvic CT included metastases of the pelvic bone (n = 1) and pelvic peritoneum (n = 3). However, the new findings did not change the primary staging. Of the three patients with pelvic peritoneal metastasis, two were already determined with peritoneal involvement and ascites by abdominal CT, and the third patient was observed with liver and distant lymph node metastasis. Thus, none of their initial stagings needed to be changed.

Conclusion: The addition of pelvic CT to the pre-treatment imaging strategy cannot provide added clinical benefit for the primary evaluation of rectal cancer.

Keywords: Rectal cancer, diagnosis, magnetic resonance imaging, computed tomography, pelvic, metastasis.

[1]
Beets-Tan RG, Beets GL, Borstlap AC, et al. Preoperative assessment of local tumor extent in advanced rectal cancer: CT or high-resolution MRI? Abdom Imaging 2000; 25(5): 533-41.
[http://dx.doi.org/10.1007/s002610000086 ] [PMID: 10931993]
[2]
Bogach J, Tsai S, Zbuk K, et al. Quality of preoperative pelvic computed tomography (CT) and magnetic resonance imaging (MRI) for rectal cancer in a region in Ontario: A retrospective population-based study. J Surg Oncol 2018; 117(5): 1038-42.
[http://dx.doi.org/10.1002/jso.25000 ] [PMID: 29473947]
[3]
Kobayashi H, Kikuchi A, Okazaki S, et al. Diagnostic performance of multidetector row computed tomography for assessment of lymph node metastasis in patients with distal rectal cancer. Ann Surg Oncol 2015; 22(1): 203-8.
[http://dx.doi.org/10.1245/s10434-014-3972-3 ] [PMID: 25124470]
[4]
Silva-Velazco J, Dietz DW, Stocchi L, et al. Considering value in rectal cancer surgery: an analysis of costs and outcomes based on the open, laparoscopic, and robotic approach for proctectomy. Ann Surg 2017; 265(5): 960-8.
[http://dx.doi.org/10.1097/SLA.0000000000001815 ] [PMID: 27232247]
[5]
Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM In: Annals of surgical oncology. 2010. 17: p. (6)1471-4.
[6]
Hartman RI, Chang CY, Wo JY, et al. Optimizing adjuvant treatment decisions for stage t2 rectal cancer based on mesorectal node size: A decision analysis. Acad Radiol 2013; 20(1): 79-89.
[http://dx.doi.org/10.1016/j.acra.2012.07.010 ] [PMID: 22947271]
[7]
Pomerri F, Maretto I, Pucciarelli S, et al. Prediction of rectal lymph node metastasis by pelvic computed tomography measurement. Eur J Surg Oncol 2009; 35(2): 168-73.
[8]
Kim SH, Lee JM, Park HS, Eun HW, Han JK, Choi BI. Accuracy of MRI for predicting the circumferential resection margin, mesorectal fascia invasion, and tumor response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer. J Magn Reson Imaging 2009; 29(5): 1093-101.
[http://dx.doi.org/10.1002/jmri.21742 ] [PMID: 19388124]
[9]
Smith NJ, Barbachano Y, Norman AR, Swift RI, Abulafi AM, Brown G. Prognostic significance of magnetic resonance imaging-detected extramural vascular invasion in rectal cancer. Br J Surg 2008; 95(2): 229-36.
[http://dx.doi.org/10.1002/bjs.5917 ] [PMID: 17932879]
[10]
Adeyemo D, Hutchinson R. Preoperative staging of rectal cancer: pelvic MRI plus abdomen and pelvic CT. Does extrahepatic abdomen imaging matter? A case for routine thoracic CT. Colorectal Dis 2009; 11(3): 259-63.
[11]
Satoh Y, Ichikawa T, Motosugi U, et al. Diagnosis of peritoneal dissemination: comparison of 18F-FDG PET/CT, diffusion-weighted MRI, and contrast-enhanced MDCT. AJR Am J Roentgenol 2011; 196(2): 447-53.
[http://dx.doi.org/10.2214/AJR.10.4687 ] [PMID: 21257899]
[12]
Michielsen K, Dresen R, Vanslembrouck R, et al. Diagnostic value of whole body diffusion-weighted MRI compared to computed tomography for pre-operative assessment of patients suspected for ovarian cancer. Eur J Cancer 2017; 83: 88-98.
[http://dx.doi.org/10.1016/j.ejca.2017.06.010 ] [PMID: 28734146]
[13]
Schmidt S, Meuli RA, Achtari C, Prior JO. Peritoneal carcinomatosis in primary ovarian cancer staging: Comparison between MDCT, MRI, and 18F-FDG PET/CT. Clin Nucl Med 2015; 40(5): 371-7.
[http://dx.doi.org/10.1097/RLU.0000000000000768 ] [PMID: 25783507]
[14]
Ricke J, Sehouli J, Hach C, Hänninen EL, Lichtenegger W, Felix R. Prospective evaluation of contrast-enhanced MRI in the depiction of peritoneal spread in primary or recurrent ovarian cancer. Eur Radiol 2003; 13(5): 943-9.
[PMID: 12695813]
[15]
Kitajima K, Tanaka U, Ueno Y, Maeda T, Suenaga Y, Takahashi S, et al. Role of diffusion weighted imaging and contrast-enhanced MRI in the evaluation of intrapelvic recurrence of gynecological malignant tumor. PLoS One 2015; 10(1)e0117411
[http://dx.doi.org/10.1371/journal.pone.0117411 ] [PMID: 25629156]
[16]
Lahaye MJ, Engelen SM, Nelemans PJ, et al. Imaging for predicting the risk factors--the circumferential resection margin and nodal disease--of local recurrence in rectal cancer: A meta-analysis. Semin Ultrasound CT MR 2005; 26(4): 259-68.
[http://dx.doi.org/10.1053/j.sult.2005.04.005 ] [PMID: 16152740]
[17]
Tudyka V, Blomqvist L, Beets-Tan RG, et al. EURECCA consensus conference highlights about colon & rectal cancer multidisciplinary management: the radiology experts review. Eur J Surg Oncol 2014; 40(4): 469-75.

Rights & Permissions Print Cite
Article Metrics
22
2
© 2024 Bentham Science Publishers | Privacy Policy